More Strength to Healthcare Sector: Generative AI & Its Application in HealthTech



It is no secret that technology plays a significant role in daily living. As a result, we have started to trust technologies more. This has been a significant motivation for well-known healthcare organizations to prioritize digitization to make their systems resilient and future-ready. One of the latest focus areas is Generative AI, thanks to its potential to dramatically transform the sector. With generative AI systems, it is feasible to create new content and analyze large amounts of medical data. Furthermore, generative AI overcomes some of the earlier obstacles to applying AI in healthcare. It requires less information, is more adaptable in fresh situations, and communicates with healthcare experts more efficiently. These qualities make generative AI more flexible and appropriate for a range of healthcare positions.

What are the Key Uses Cases of Generative AI in the Healthcare Sector?

Foremost, let us look into the segments that are using Generative AI in the Healthcare process.

Healthcare Providers: Several generative AI providers are creating solutions for diagnosis, care provision, and patient monitoring to help healthcare workers in improving clinical outcomes.

Validated Products in Use at Present: To increase the precision and effectiveness of prostate cancer detection, generative AI is included in AI products in digital pathology companies. It got FDA certification for AI usage in digital pathology, and the companies plan to incorporate the generated data and other clinical data into patient electronic health records.

On the administrative front, applications that automate procedures like documentation, claims processing, preauthorization and appeals, patient onboarding, and scheduling are being looked into by Doximity, Abridge, and DeepScribe. Abridge's ambient AI scribing products are now in use at more than 140 provider locations in the University of Kansas Health System, and DeepScribe, which provides AI scribing services, has been able to reduce the amount of time clinicians spend on administrative activities by three hours each day, as per reports. 

Early-Stage/Conceptual Use Cases: Some providers are creating interactive digital solutions for patients to help carers. According to reports, Babylon Health has developed a digital health service that employs generative AI to comprehend patients' changing risk profiles and enable providers to give more specialized care at a reduced cost. Accessible and reasonably priced mental health care is provided via a generative AI-powered counselling chatbot offered on demand by Serena.

Potential Future Use Cases: The use of generative AI in the future may enable real-time patient monitoring and data analysis to produce personalized insights that promote healthy behavior or prompt treatments before medical conditions deteriorate. Additionally, generative AI might improve the accuracy and adaptability of imaging technologies for use in various clinical settings. Personalized nudges on mobile apps, wearables, and monitoring devices may also be used by technology to promote preventative care, wellness, and healthy behaviors.

 Generative AI in Pharmaceutical Firms

Generative AI is accelerating drug discovery, improving clinical-trial planning and execution, and leading to more precision medicine therapies.

Validated Products in Use at Present: With under $2.6 million in expenditures, Generative AI-enabled Insilico Medicine to advance from novel-target discovery to preclinical candidate in just 18 months. The company's treatment for idiopathic pulmonary fibrosis recently acquired the agency's Orphan Drug Designation after finishing the preclinical phase in 30 months, which is substantially quicker than the typical time for a new medication.

Exscientia, a biotech startup, is utilizing functional precision oncology and generative AI to analyze patient tissue and enhance patient outcomes. In order to speed up drug development and research in genomics, chemistry, biology, and molecular dynamics, NVIDIA is providing a set of generative AI cloud services that allow customization of AI foundation models. Researchers can improve generative AI applications on their own proprietary data by using the services' pre-trained models, which are provided. Both established companies like Amgen and up-and-coming drug research firms like Evozyne and Insilico Medicine have adopted the offering.

Conceptual Use Cases: Several biotech firms are at an earlier stage of generative AI exploration:

  • Ordaōs is developing a class of min proteins with enhanced biological and therapeutic attributes to treat uniquely challenging rare cancers primarily affecting ethnic minorities.
  • Absci is using deep-learning AI and synthetic biology to design new antibodies against cancers and immune diseases.
  • Profluent created a machine-learning model able to generate new protein sequences with specific functions, an innovative tool that can help improve access to affordable treatments.

Beyond the development of new drugs, generative AI has the potential to hasten and enhance clinical trials and precision medicine treatments. For instance, digital modeling of clinical trials, including artificial control groups, has recently received validation. Similarly, a tool Synthesised created can assist researchers in extending current pharmaceuticals beyond their original usage to treat different ailments, which could make medicines more affordable.


Potential Future Use Cases: In the future, the use of generative AI at the preclinical and clinical stages may hasten access to treatments, especially for rare illnesses for which developing a treatment has proven challenging or expensive. The technology may also be used to analyze patient data in order to pinpoint patient subgroups that are more likely to respond to particular therapies or to tailor medications to each patient's particular need.

Generative AI in Medtech

By including software that enables preventive maintenance and repairs, for instance, generative AI might assist businesses in developing more individualized and patient-centered products.

Early-Stage/Conceptual Use Cases: The National Centre for Additive Manufacturing in the UK is using generative AI to improve the design of medical items like implants and prosthetics and customize them to the needs of specific patients. The technique is also being used by the medical technology company Implicity to include remote monitoring in pacemakers and implantable defibrillators.

Data analytics and software optimization are two areas where generative AI can be especially helpful in the healthcare industry. Generative AI can enhance the interoperability of current applications, such as health and laboratory information management systems. It is more adaptable than earlier generations of AI, can accommodate different data modes and formats, and even generate synthetic data to supplement insufficient data sets.

Current Issue